.
MergerLinks Header Logo

Announced

Completed

Recordati completed the acquisition of EUSA Pharma from EW Healthcare for $849m.

Financials

Edit Data
Transaction Value£638m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Cross Border

United Kingdom

Pharmaceuticals

Public

Single Bidder

Private Equity

rare diseases

Friendly

cancer

Acquisition

Majority

Completed

Synopsis

Edit

Recordati, an international pharmaceutical group, completed the acquisition of EUSA Pharma, a dynamic, global speciality pharmaceutical company, from EW Healthcare, one of the oldest and most respected healthcare growth equity firms in the world, for $849m. The transaction provides Recordati with an expanded portfolio of rare disease pharmaceutical products.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US